found that CS-Iva-Be, which is a special IL6R antagonist, inhibited the IL6/STAT3 pathway and sensitized breast cancer cells to TRAIL-induced cell apoptosis (40). The gene discussed is TNFSF10; the disease is breast carcinoma.